Reck Reck M M Updated analysis of KEYNOTE-024: pembrolizumab versus platinum-based chemotherapy for advanced non-small-cell lung cancer with PD-L1 tumor proportion score of 50 % or greater Updated analysis of KEYNOTE-024: pembrolizumab versus platinum-based chemotherapy for advanced non-small-cell lung cancer with PD-L1 tumor proportion score of 50 % or greater J Clin Oncol J Clin Oncol 2019 2019 10.1200/JCO.18.00149 10.1200/JCO.18.00149 supplied-pmid 30785829? This evidence concerns the gene CD274 and neoplasm.